Detection platform for multiple pathogens

Seegene and Lab901 have announced an automated multi-pathogen walk-away detection platform for European hospitals. Based on the Seeplex multiplexing PCR system and ScreenTape gel electrophoresis detection system, this Seeplex/ScreenTape detection platform is being introduced to clinical and research laboratories in 10 countries across Europe.

Seegene and Lab901 have agreed to co-market the testing solutions in the European market. The two companies are responding to requests in Europe for a new automated testing technique to perform what is a routine, but not always consistent, test for biological agents in clinics. Hospital centres in the Netherlands, United Kingdom, Spain, Italy, Norway, Greece, Austria, France, Israel and Turkey have started demonstrations of the automated Seeplex/ScreenTape system.

The automated Seeplex/ScreenTape tests are based on a Seeplex multiplexing PCR technology from Seegene, which is capable of detecting multiple pathogens in a single tube, and ScreenTape, an automated walk-away gel electrophoresis detection system from Lab901.

The Seeplex tests with the CE mark and ISO 13485 deliver maximum specificity, reproducibility and sensitivity and can be supplied to a broad range of molecular diagnostics, including human, animal, plant and microorganisms. The ScreenTape system will automate the simultaneous analysis of eight or 16 Seeplex PCR samples. Processing speed for eight samples is completed within 10 mins; 16 samples within 18 mins. ScreenTape displays results using an easy to interpret positive and negative read-out. With no gel or buffer preparation and no system priming, even untrained operators can rapidly generate accurate and reproducible test data.

The automated Seeplex/ScreenTape tests are currently available for sexually transmitted diseases (STDs), human papillomavirus (HPV), respiratory viruses (RVs) and bacterial pneumonia (PB).